ERA - Leading European Nephrology

My ERA Unisciti a ERA

Home | Video pages | Webcast | GLP-1 receptor agonists in patients with CKD not on dialysis; beyond cardiorenal protection

GLP-1 receptor agonists in patients with CKD not on dialysis; beyond cardiorenal protection

Condividi

https://www.youtube.com/watch?v=2QtDnRAWHa0 copia

Other e-seminars from EuReCa-M & Diabesity

What does the Cardiovascular-Kidney-Metabolic (CKM) Syndrome mean for nephrologists?

SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

The impact of novel anticancer therapies on blood pressure and kidney function in patients with CKD

The role of exercise in patients with renal disease and metabolic syndrome

Heart failure in patients with CKD: diagnosis and therapeutic approaches

Calcification propensity: from biomarker to treatment target?

Crosstalk between bone and the vasculature in diabetes and CKD

Assessment and management of hypertension in dialysis patients

Echocardiography or Cardiac Magnetic resonance Imaging (or both) for cardiac assessment in CKD patients?

Physical Activity in CKD patients: time to overcome nephrologist’s inertia

Role of Hidden Vascular Lesions in Diabetic Nephropathy

Let´s talk about sex: disparities in the outcomes and quality of care of men and women with kidney disease